University of Florida: Prostatic Neoplasms trials
The registry lists 19 Prostatic Neoplasms studies with University of Florida as lead sponsor. 5 are open to participants now and 3 have results posted.
Phase 1 3Phase 2 7No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsRecruitingNCT07220720Phase 2
- The Florida ASCENT StudyRecruitingNCT07042243Not applicable
- High Intensity Focused Ultrasound in Prostate CancerRecruitingNCT06402357Phase 2
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsRecruitingNCT05655494
- Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/2
- Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerCompletedNCT01040624Not applicableResults posted
- RNActive®-Derived Therapeutic VaccineTerminatedNCT00906243Phase 1/2Results posted
- Proton Therapy for Low and Intermediate Risk Prostate CancerCompletedNCT00693238Not applicableResults posted
- UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam ScanningActive, not recruitingNCT06465966Not applicable
- Dose-Escalated Proton Radiation Therapy for High-Risk Prostate CancerActive, not recruitingNCT03624660Phase 2
- A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerActive, not recruitingNCT03561220Not applicable
- Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)WithdrawnNCT03296124
- RADTOX: Measuring Radiation Toxicity Using Circulating DNACompletedNCT02941029
- Relationship of Mitochondrial Enzymes With Cancer Related FatigueCompletedNCT02414971
- Radiotherapy for Oligometastatic Prostate CancerCompletedNCT01859221Not applicable
- Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate CancerCompletedNCT01368055Not applicable
- Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell VaccinesWithdrawnNCT01153113Phase 1/2
- Semen Analysis After Proton Therapy for Prostate CancerCompletedNCT01072513Not applicable
- Isoflavone in Prostate-specific Antigen Recurrent Prostate CancerCompletedNCT00596895Phase 2